219 related articles for article (PubMed ID: 23108308)
1. TGF-β signaling in onset and progression of hepatocellular carcinoma.
Meindl-Beinker NM; Matsuzaki K; Dooley S
Dig Dis; 2012; 30(5):514-23. PubMed ID: 23108308
[TBL] [Abstract][Full Text] [Related]
2. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma.
Dooley S; Weng H; Mertens PR
Dig Dis; 2009; 27(2):93-101. PubMed ID: 19546546
[TBL] [Abstract][Full Text] [Related]
3. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
[TBL] [Abstract][Full Text] [Related]
4. TGF-β in progression of liver disease.
Dooley S; ten Dijke P
Cell Tissue Res; 2012 Jan; 347(1):245-56. PubMed ID: 22006249
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
Yamazaki K; Masugi Y; Sakamoto M
Dig Dis; 2011; 29(3):284-8. PubMed ID: 21829019
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells.
Caja L; Sancho P; Bertran E; Fabregat I
J Hepatol; 2011 Aug; 55(2):351-8. PubMed ID: 21147185
[TBL] [Abstract][Full Text] [Related]
7. TGF-β signalling and liver disease.
Fabregat I; Moreno-Càceres J; Sánchez A; Dooley S; Dewidar B; Giannelli G; Ten Dijke P;
FEBS J; 2016 Jun; 283(12):2219-32. PubMed ID: 26807763
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.
Carmona-Cuenca I; Roncero C; Sancho P; Caja L; Fausto N; Fernández M; Fabregat I
J Hepatol; 2008 Dec; 49(6):965-76. PubMed ID: 18845355
[TBL] [Abstract][Full Text] [Related]
9. Integration of Ras subeffector signaling in TGF-beta mediated late stage hepatocarcinogenesis.
Fischer AN; Herrera B; Mikula M; Proell V; Fuchs E; Gotzmann J; Schulte-Hermann R; Beug H; Mikulits W
Carcinogenesis; 2005 May; 26(5):931-42. PubMed ID: 15705598
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta/Smad signaling in the injured liver.
Breitkopf K; Godoy P; Ciuclan L; Singer MV; Dooley S
Z Gastroenterol; 2006 Jan; 44(1):57-66. PubMed ID: 16397841
[TBL] [Abstract][Full Text] [Related]
11. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of apoptosis in hepatocellular carcinoma.
Thorgeirsson SS; Teramoto T; Factor VM
Semin Liver Dis; 1998; 18(2):115-22. PubMed ID: 9606809
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
Kao YH; Chen CL; Jawan B; Chung YH; Sun CK; Kuo SM; Hu TH; Lin YC; Chan HH; Cheng KH; Wu DC; Goto S; Cheng YF; Chao D; Tai MH
J Hepatol; 2010 Jan; 52(1):96-105. PubMed ID: 19913322
[TBL] [Abstract][Full Text] [Related]
15. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
Paik SY; Park YN; Kim H; Park C
Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
[TBL] [Abstract][Full Text] [Related]
17. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression.
Fischer AN; Fuchs E; Mikula M; Huber H; Beug H; Mikulits W
Oncogene; 2007 May; 26(23):3395-405. PubMed ID: 17130832
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta and cancer.
Bierie B; Moses HL
Cytokine Growth Factor Rev; 2006; 17(1-2):29-40. PubMed ID: 16289860
[TBL] [Abstract][Full Text] [Related]
19. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
20. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
